Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$73.18 - $82.95 $12.6 Million - $14.3 Million
-172,310 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $12.1 Million - $13.8 Million
172,310 New
172,310 $13.3 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $33.8 Million - $46.8 Million
-533,210 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $79.5 Million - $89.7 Million
-1,025,080 Reduced 65.78%
533,210 $48.5 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $20.2 Million - $22 Million
265,880 Added 20.57%
1,558,290 $131 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $2.49 Million - $2.9 Million
35,600 Added 2.83%
1,292,410 $108 Million
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $44 Million - $50.2 Million
632,730 Added 101.39%
1,256,810 $105 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $232 Million - $270 Million
-3,560,080 Reduced 85.08%
624,080 $47.7 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $116 Million - $134 Million
1,775,280 Added 73.7%
4,184,160 $254 Million
Q3 2018

Nov 15, 2018

SELL
$57.69 - $67.84 $102 Million - $120 Million
-1,775,280 Reduced 42.43%
2,408,880 $171 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $26.8 Million - $31.4 Million
526,340 Added 14.39%
4,184,160 $254 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $12.3 Million - $14.3 Million
-242,180 Reduced 6.21%
3,657,820 $199 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $166 Million - $198 Million
3,208,720 Added 464.17%
3,900,000 $219 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $40.6 Million - $43.6 Million
691,280
691,280 $44.3 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Health Cor Management, L.P. Portfolio

Follow Health Cor Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Health Cor Management, L.P. with notifications on news.